Inderes repeats its Add recommendation and price target of 14 euros for contract manufacturer Scanfil following a third-quarter report in line with earnings expectations.
Revenue rose 32 percent to 252 million euros, while adjusted EBITA increased 26 percent to 17.8 million euros. The company’s full-year forecast was reiterated, and Inderes leaves its earnings estimates largely unchanged.
The research house expects annual earnings growth of approximately 15 percent through 2028. The stock trades at 11 times expected 2027 EBITA and is valued 10–20 percent lower than global peers.
